ANI Pharmaceuticals 2026 Watchlist: Gout Sales Force and Rare Disease [Yahoo! Finance]
ANI Pharmaceuticals, Inc. (ANIP)
Last ani pharmaceuticals, inc. earnings: 2/27 08:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
anipharmaceuticals.com/investors_corporate_profile.php
Company Research
Source: Yahoo! Finance
Management expects Rare Disease to represent about 60% of 2026 sales, signaling a continued shift toward higher-margin therapies led by Cortrophin Gel. That pivot comes as the company works to re-accelerate its retina franchise after a reimbursement-driven “reset year” in 2025 and keep a steady generics engine running in the background. ANI Pharmaceuticals' 2026 Is About Rare Disease Scale-Up The center of gravity is moving toward Rare Disease, with management expecting that segment to contribute roughly 60% of 2026 sales. Cortrophin Gel sits at the core of that strategy, having become the company's primary growth engine and anchor for a specialty-focused commercial model. The growth profile has been supported by under-penetration across addressable markets and expanding use across rheumatology, nephrology, and pulmonology. For investors, 2026 execution should increasingly be judged by whether this specialty mix shift translates into sustained revenue momentum and improved pro
Show less
Read more
Impact Snapshot
Event Time:
ANIP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANIP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANIP alerts
High impacting ANI Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ANIP
News
- ANI Pharma Insider Sells 4,772 Shares as Revenue Hits $883 Million in 2025 [Yahoo! Finance]Yahoo! Finance
- 3 Reasons ANIP is Risky and 1 Stock to Buy Instead [Yahoo! Finance]Yahoo! Finance
- ANI Pharmaceuticals Expands Ophthalmology Reach As Valuation Signals Upside Potential [Yahoo! Finance]Yahoo! Finance
- Sizing Up ANI Pharmaceuticals (ANIP) After Recent Share Price Pullback [Yahoo! Finance]Yahoo! Finance
- ANI Pharmaceuticals, Inc. (ANIP) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]Seeking Alpha
ANIP
Earnings
- 2/27/26 - Beat
ANIP
Sec Filings
- 3/26/26 - Form SCHEDULE
- 3/13/26 - Form 4
- 3/13/26 - Form 4
- ANIP's page on the SEC website